Oxidative Modification of Blood Serum Proteins in Multiple Sclerosis after Interferon Beta and Melatonin Treatment

Figure 8

Comparison of “fast” (a) and “slow” (b) ABTS scavenging activity of blood serum proteins in healthy controls, in RRMS patients without treatment, in RRMS patients treated with INF-beta, and in RRMS patients treated with INF-beta and MEL.

(a)

(b)